retatrutide weight loss study Lilly's triple agonist achieves 16.8% in phase 3 trial Retatrutide—A Game Changer in Obesity

If the underlying dietary patterns have not changed, and if you cannot afford to continue the medication long-term, the weight lost is likely to return, and potentially with additional muscle loss, making the situation worse than before

Diabetologia 52 , 199207 (2009)

A calibration for niclosamide concentration (y) versus UV absorbance at 333nm (x) was first obtained on a Thermo Scientific Nanodrop 1000 UV/Vis Spectrophotometer over the range 25uM-300uM niclosamide, providing a linear fit of y = 0.0014x - 0.0006

But price should be one factor among many, not the only factor

If youre like eh its fine, save your money.

The results indicated that the overall prevalence of zinc deficiency in this cohort was 23.2%, with 72.4% of participants exhibiting dietary zinc intake levels below the estimated average requirement (EAR)